436.95
price up icon0.15%   0.67
after-market アフターアワーズ: 435.50 -1.45 -0.33%
loading
前日終値:
$436.28
開ける:
$444.09
24時間の取引高:
176.60K
Relative Volume:
0.47
時価総額:
$9.70B
収益:
-
当期純損益:
$-518.67M
株価収益率:
-17.39
EPS:
-25.12
ネットキャッシュフロー:
$-438.32M
1週間 パフォーマンス:
-2.71%
1か月 パフォーマンス:
-3.71%
6か月 パフォーマンス:
+44.31%
1年 パフォーマンス:
+101.57%
1日の値動き範囲:
Value
$435.21
$444.09
1週間の範囲:
Value
$433.00
$462.88
52週間の値動き範囲:
Value
$200.63
$463.62

Madrigal Pharmaceuticals Inc Stock (MDGL) Company Profile

Name
名前
Madrigal Pharmaceuticals Inc
Name
セクター
Healthcare (1141)
Name
電話
404-380-9263
Name
住所
200 BARR HARBOR DRIVE, SUITE 400, WEST CONSHOHOCKEN, PA
Name
職員
528
Name
Twitter
@MadrigalPharma
Name
次回の収益日
2024-10-31
Name
最新のSEC提出書
Name
MDGL's Discussions on Twitter

MDGL を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
MDGL
Madrigal Pharmaceuticals Inc
436.95 9.72B 0 -518.67M -438.32M -25.12
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
421.15 105.19B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
450.68 60.24B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
563.86 61.82B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
798.94 49.09B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
351.09 37.52B 4.56B -176.77M 225.30M -1.7177

Madrigal Pharmaceuticals Inc Stock (MDGL) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-09-04 再開されました H.C. Wainwright Buy
2025-02-28 アップグレード B. Riley Securities Neutral → Buy
2025-02-27 繰り返されました H.C. Wainwright Buy
2024-06-28 開始されました Cantor Fitzgerald Neutral
2024-06-11 開始されました Wolfe Research Outperform
2024-04-22 開始されました BofA Securities Underperform
2024-03-15 アップグレード B. Riley Securities Sell → Neutral
2024-03-06 開始されました Citigroup Buy
2024-02-26 ダウングレード B. Riley Securities Neutral → Sell
2022-12-20 繰り返されました Oppenheimer Outperform
2022-12-19 繰り返されました H.C. Wainwright Buy
2022-12-19 繰り返されました Piper Sandler Overweight
2022-12-19 アップグレード Raymond James Underperform → Mkt Perform
2022-07-08 ダウングレード B. Riley Securities Buy → Neutral
2021-10-07 開始されました Jefferies Buy
2021-08-06 アップグレード BMO Capital Markets Market Perform → Outperform
2021-05-20 再開されました Goldman Buy
2020-11-24 再開されました Evercore ISI Outperform
2020-11-06 繰り返されました H.C. Wainwright Buy
2020-07-31 開始されました Piper Sandler Overweight
2020-06-05 開始されました BMO Capital Markets Market Perform
2020-05-05 開始されました Chardan Capital Markets Buy
2020-01-30 開始されました Canaccord Genuity Buy
2020-01-09 アップグレード UBS Neutral → Buy
2019-11-07 繰り返されました H.C. Wainwright Buy
2019-06-25 開始されました Stifel Hold
2019-06-10 アップグレード B. Riley FBR Neutral → Buy
2019-02-28 繰り返されました H.C. Wainwright Buy
2019-02-22 開始されました SVB Leerink Outperform
2019-01-23 開始されました UBS Neutral
2018-12-14 開始されました Wolfe Research Outperform
2018-12-12 開始されました B. Riley FBR Neutral
2018-11-19 ダウングレード Raymond James Mkt Perform → Underperform
2018-11-16 アップグレード Evercore ISI In-line → Outperform
2018-09-04 開始されました Citigroup Buy
2018-08-06 ダウングレード Goldman Buy → Neutral
2018-06-28 開始されました Raymond James Mkt Perform
すべてを表示

Madrigal Pharmaceuticals Inc (MDGL) 最新ニュース

pulisher
Oct 07, 2025

Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Oct 07, 2025
pulisher
Oct 07, 2025

Knights of Columbus Asset Advisors LLC Increases Stock Position in Madrigal Pharmaceuticals, Inc. $MDGL - MarketBeat

Oct 07, 2025
pulisher
Oct 06, 2025

How strong is Madrigal Pharmaceuticals Inc. (YDO1) stock earnings growthTrade Analysis Report & Fast Moving Stock Trade Plans - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Short interest data insights for Madrigal Pharmaceuticals Inc.Quarterly Profit Summary & AI Enhanced Trading Signals - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Will Madrigal Pharmaceuticals Inc. (YDO1) stock keep high P E multiplesJuly 2025 Rallies & Long-Term Investment Growth Plans - newser.com

Oct 06, 2025
pulisher
Oct 05, 2025

What analysts say about Madrigal Pharmaceuticals Inc YDO1 stockMarket Sentiment Shifts & Breakout Stock Alerts - earlytimes.in

Oct 05, 2025
pulisher
Oct 05, 2025

Strid Group LLC Buys Shares of 2,500 Madrigal Pharmaceuticals, Inc. $MDGL - MarketBeat

Oct 05, 2025
pulisher
Oct 05, 2025

Published on: 2025-10-05 03:01:06 - newser.com

Oct 05, 2025
pulisher
Oct 04, 2025

J. Safra Sarasin Holding AG Increases Holdings in Madrigal Pharmaceuticals, Inc. $MDGL - MarketBeat

Oct 04, 2025
pulisher
Oct 03, 2025

Madrigal Pharmaceuticals Hits New 52-Week High of $463.48 - Markets Mojo

Oct 03, 2025
pulisher
Oct 03, 2025

Signal strength of Madrigal Pharmaceuticals Inc. stock in tech scannersJuly 2025 Opening Moves & Low Risk Investment Opportunities - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Q3 Earnings Estimate for MDGL Issued By B. Riley - Defense World

Oct 03, 2025
pulisher
Oct 02, 2025

How to use Fibonacci retracement on Madrigal Pharmaceuticals Inc.Earnings Overview Report & Technical Pattern Based Signals - newser.com

Oct 02, 2025
pulisher
Oct 02, 2025

What is B. Riley's Forecast for MDGL Q3 Earnings? - MarketBeat

Oct 02, 2025
pulisher
Oct 01, 2025

Madrigal Pharmaceuticals to Present at 43rd Annual J.P. Morgan Healthcare Conference - MSN

Oct 01, 2025
pulisher
Oct 01, 2025

Madrigal Pharmaceuticals Achieves 114.43% Annual Growth, Marking It as a Multibagger Stock - Markets Mojo

Oct 01, 2025
pulisher
Oct 01, 2025

Madrigal Pharmaceuticals Hits Day High with 8.43% Surge in Stock Price - Markets Mojo

Oct 01, 2025
pulisher
Oct 01, 2025

Madrigal Pharmaceuticals Hits New 52-Week High of $460.00 - Markets Mojo

Oct 01, 2025
pulisher
Oct 01, 2025

What drives Madrigal Pharmaceuticals Inc YDO1 stock priceSupport Zone Identification & Low Risk High Yield - earlytimes.in

Oct 01, 2025
pulisher
Oct 01, 2025

Can Prince Pipes and Fittings Limited Reach New Highs in YEAR Resistance Levels ReviewedBreakout Stock Watch & Rapid Profit Growth - earlytimes.in

Oct 01, 2025
pulisher
Oct 01, 2025

Madrigal Pharmaceuticals (NASDAQ:MDGL) Reaches New 52-Week High on Analyst Upgrade - Defense World

Oct 01, 2025
pulisher
Sep 30, 2025

Madrigal Pharmaceuticals (NASDAQ:MDGL) Hits New 52-Week High After Analyst Upgrade - MarketBeat

Sep 30, 2025
pulisher
Sep 30, 2025

Madrigal Pharmaceuticals stock hits all-time high at 457.47 USD By Investing.com - Investing.com Australia

Sep 30, 2025
pulisher
Sep 30, 2025

Madrigal Pharmaceuticals stock hits all-time high at 457.47 USD - Investing.com India

Sep 30, 2025
pulisher
Sep 30, 2025

Madrigal Pharmaceuticals Advances NASH Treatment with Full Enrollment of MAESTRO-NASH OUTCOMES Trial - MSN

Sep 30, 2025
pulisher
Sep 30, 2025

Madrigal Pharmaceuticals: Rezdiffra's US And EU Rollout Remains Promising (NASDAQ:MDGL) - Seeking Alpha

Sep 30, 2025
pulisher
Sep 30, 2025

Evaluating Madrigal Pharmaceuticals Inc. with trendline analysisEntry Point & Free Community Consensus Stock Picks - newser.com

Sep 30, 2025
pulisher
Sep 30, 2025

B. Riley Issues Positive Forecast for Madrigal Pharmaceuticals (NASDAQ:MDGL) Stock Price - Defense World

Sep 30, 2025
pulisher
Sep 29, 2025

Published on: 2025-09-29 16:45:10 - newser.com

Sep 29, 2025
pulisher
Sep 29, 2025

A Glimpse Into The Expert Outlook On Madrigal Pharmaceuticals Through 7 Analysts - Benzinga

Sep 29, 2025
pulisher
Sep 29, 2025

MSN - MSN

Sep 29, 2025
pulisher
Sep 29, 2025

MDGL: B. Riley Securities Raises Price Target to $560 | MDGL Sto - GuruFocus

Sep 29, 2025
pulisher
Sep 29, 2025

B. Riley Raises Price Target on Madrigal Pharmaceuticals to $560 From $460, Keeps Buy Rating - MarketScreener

Sep 29, 2025
pulisher
Sep 29, 2025

Madrigal Pharmaceuticals, Inc. (MDGL) Stock Analysis: Exploring Growth Potential Amid 1,353.80% Revenue Surge - DirectorsTalk Interviews

Sep 29, 2025
pulisher
Sep 29, 2025

Madrigal Pharmaceuticals, Inc. (MDGL) Stock Analysis: Unveiling a 13.58% Potential Upside with Robust Revenue Growth - DirectorsTalk Interviews

Sep 29, 2025
pulisher
Sep 29, 2025

Published on: 2025-09-28 23:27:34 - newser.com

Sep 29, 2025
pulisher
Sep 28, 2025

What drives Madrigal Pharmaceuticals Inc stock priceSupport and Resistance Levels & Rapid Capital Trading - Early Times

Sep 28, 2025
pulisher
Sep 28, 2025

Is Madrigal Pharmaceuticals Inc a good long term investmentAI-Driven Market Analysis & Big Profit Low Investment - earlytimes.in

Sep 28, 2025
pulisher
Sep 28, 2025

Published on: 2025-09-28 01:35:26 - newser.com

Sep 28, 2025
pulisher
Sep 27, 2025

Madrigal Pharmaceuticals Announces Positive Quality of Life Outcomes for Rezdiffra in NASH Treatment - MSN

Sep 27, 2025
pulisher
Sep 27, 2025

What analysts say about Madrigal Pharmaceuticals Inc stockSupport Zone Identification & Unlock Long-Term Capital Growth Ideas - Early Times

Sep 27, 2025
pulisher
Sep 27, 2025

Madrigal Pharmaceuticals Inc Stock Analysis and ForecastAutomated Trading Signals & Low Entry Capital Stocks - Early Times

Sep 27, 2025
pulisher
Sep 25, 2025

Madrigal Pharmaceuticals (MDGL) Gets a Buy from UBS - The Globe and Mail

Sep 25, 2025
pulisher
Sep 23, 2025

Strs Ohio Acquires Shares of 1,900 Madrigal Pharmaceuticals, Inc. $MDGL - MarketBeat

Sep 23, 2025

Madrigal Pharmaceuticals Inc (MDGL) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$85.38
price down icon 2.05%
$23.34
price up icon 4.71%
$32.74
price up icon 0.31%
$106.28
price up icon 0.21%
$161.81
price down icon 0.31%
biotechnology ONC
$351.09
price up icon 2.77%
大文字化:     |  ボリューム (24 時間):